Login / Signup

Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics.

Antonio Jesús Martínez-OrtegaÁlvaro Flores-MartinezEva Venegas-MorenoElena DiosDiego Jesús Del Can SánchezEloy RivasAriel KaenEugenio Cárdenas Ruiz-ValdepeñasElena FajardoFlorinda RoldánNatividad González-RiveraRosario OlivaJosé Ignacio Fernández-PeñaAlfonso Soto-MorenoDavid A Cano
Published in: Journal of clinical medicine (2022)
Craniopharyngiomas (CPs) are rare tumors of the sellar and suprasellar regions of embryonic origin. The primary treatment for CPs is surgery but it is often unsuccessful. Although CPs are considered benign tumors, they display a relatively high recurrence rate that might compromise quality of life. Previous studies have reported that CPs express sex hormone receptors, including estrogen and progesterone receptors. Here, we systematically analyzed estrogen receptor α (ERα) and progesterone receptor (PR) expression by immunohistochemistry in a well-characterized series of patients with CP ( n = 41) and analyzed their potential association with tumor aggressiveness features. A substantial proportion of CPs displayed a marked expression of PR. However, most CPs expressed low levels of ERα. No major association between PR and ERα expression and clinical aggressiveness features was observed in CPs. Additionally, in our series, β-catenin accumulation was not related to tumor recurrence.
Keyphrases
  • estrogen receptor
  • poor prognosis
  • binding protein
  • cell proliferation
  • breast cancer cells
  • risk assessment
  • coronary artery disease
  • human health
  • signaling pathway